Accelerate Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Accelerate Diagnostics
AXDX Stock  USD 1.13  0.04  3.67%   
Accelerate Diagnostics financial statements provide useful quarterly and yearly information to potential Accelerate Diagnostics investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Accelerate Diagnostics financial statements helps investors assess Accelerate Diagnostics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Accelerate Diagnostics' valuation are summarized below:
Gross Profit
2.9 M
Market Capitalization
27.3 M
Enterprise Value Revenue
5.5505
Revenue
11.9 M
Earnings Share
(2.59)
We have found one hundred twenty available fundamental signals for Accelerate Diagnostics, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Accelerate Diagnostics prevailing market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. Market Cap is likely to drop to about 9.9 M in 2025. Enterprise Value is likely to drop to about 9.6 M in 2025

Accelerate Diagnostics Total Revenue

14.56 Million

Check Accelerate Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Accelerate Diagnostics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.9 M, Interest Expense of 9.3 M or Selling General Administrative of 41.3 M, as well as many indicators such as Price To Sales Ratio of 3.47, Dividend Yield of 2.0E-4 or Days Sales Outstanding of 86.7. Accelerate financial statements analysis is a perfect complement when working with Accelerate Diagnostics Valuation or Volatility modules.
  
Check out the analysis of Accelerate Diagnostics Correlation against competitors.
For more information on how to buy Accelerate Stock please use our How to Invest in Accelerate Diagnostics guide.

Accelerate Diagnostics Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets48.2 M36.1 M72.8 M
Pretty Stable
Other Current Liabilities4.1 M3.9 M2.8 M
Slightly volatile
Total Current Liabilities14.5 M13.8 M9.9 M
Slightly volatile
Property Plant And Equipment Net6.1 M5.8 M4.9 M
Slightly volatile
Accounts Payable5.8 M5.5 M2.3 M
Slightly volatile
Cash23.7 M14 M34.8 M
Very volatile
Non Current Assets Total5.4 M7.9 M6.1 M
Slightly volatile
Cash And Short Term Investments14.4 M15.2 M58.7 M
Very volatile
Net Receivables3.2 M3 M1.5 M
Slightly volatile
Common Stock Shares Outstanding15.1 M14.3 M6 M
Slightly volatile
Liabilities And Stockholders Equity48.2 M36.1 M72.8 M
Pretty Stable
Non Current Liabilities Total23.3 M45.1 M40.6 M
Slightly volatile
Other Current Assets6.4 M6.1 M1.8 M
Slightly volatile
Other Stockholder Equity784.4 M747 M351.2 M
Slightly volatile
Total Liabilities61.9 M58.9 M52 M
Slightly volatile
Property Plant And Equipment Gross19.4 M18.5 M7.2 M
Slightly volatile
Total Current Assets42.8 M28.1 M66.7 M
Pretty Stable
Common Stock Total Equity49.6 K52.2 K3.5 M
Slightly volatile
Common Stock12 K12.6 K2.9 M
Slightly volatile
Current Deferred Revenue1.9 M1.8 M554.8 K
Slightly volatile
Other Liabilities1.5 M1.4 M882 K
Pretty Stable
Property Plant Equipment9.4 M8.9 M5.1 M
Slightly volatile
Intangible Assets97.5 K102.6 K355.1 K
Slightly volatile
Good Will97.5 K102.6 K590 K
Slightly volatile
Inventory2.7 M3.8 M3.5 M
Slightly volatile
Short Term Debt2.5 M2.6 M4.4 M
Slightly volatile
Capital Surpluse701.1 M667.7 M347.6 M
Slightly volatile
Non Current Liabilities Other1.6 M1.3 M1.4 M
Slightly volatile
Short and Long Term Debt Total86.9 M45.1 M62.8 M
Slightly volatile
Long Term Debt Total110.9 M124.2 M82.2 M
Slightly volatile
Short and Long Term Debt793.2 K834.9 K3.9 M
Pretty Stable
Net Invested Capital14.5 M15.2 M94 M
Slightly volatile
Capital Stock12 K12.6 K50.7 K
Slightly volatile

Accelerate Diagnostics Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization3.9 M3.7 M2.2 M
Slightly volatile
Selling General Administrative41.3 M39.3 M29.7 M
Slightly volatile
Total Revenue14.6 M13.9 M6.2 M
Slightly volatile
Other Operating Expenses79.8 M76 M53.6 M
Slightly volatile
Total Operating Expenses68.3 M65.1 M49.2 M
Slightly volatile
Research Development30.6 M29.2 M19.8 M
Slightly volatile
Selling And Marketing Expenses7.1 K7.5 K88.5 K
Slightly volatile
Non Recurring2.4 K2.7 K2.9 K
Slightly volatile
Interest Income1.2 M1.5 M806.8 K
Slightly volatile
Reconciled Depreciation3 M3.7 M2.6 M
Slightly volatile

Accelerate Diagnostics Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow23.2 M40.1 M35.4 M
Slightly volatile
Depreciation3.9 M3.7 M2 M
Slightly volatile
End Period Cash Flow23.7 M14 M34.8 M
Very volatile
Total Cash From Financing Activities9.9 M10.4 M34.6 M
Very volatile
Change To Netincome11.6 M8.3 M9 M
Slightly volatile
Issuance Of Capital Stock4.4 M4.6 M6 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.473.652.3 K
Slightly volatile
Dividend Yield2.0E-42.0E-40.01
Slightly volatile
Days Sales Outstanding86.791.27183
Slightly volatile
Average Payables284.9 K271.4 K292.5 K
Pretty Stable
Stock Based Compensation To Revenue0.490.5121.6557
Slightly volatile
Capex To Depreciation0.490.291.0275
Slightly volatile
EV To Sales5.395.672.2 K
Slightly volatile
Inventory Turnover1.753.31.0579
Slightly volatile
Days Of Inventory On Hand1391461.5 K
Slightly volatile
Payables Turnover2.562.281.9377
Slightly volatile
Sales General And Administrative To Revenue84.480.3878.0685
Slightly volatile
Average Inventory774 K737.1 K710.9 K
Slightly volatile
Research And Ddevelopement To Revenue1.81.8957.7856
Slightly volatile
Capex To Revenue0.07340.07726.2673
Slightly volatile
Cash Per Share0.910.9512.3626
Slightly volatile
Days Payables Outstanding157166410
Slightly volatile
Income Quality1.130.750.7178
Slightly volatile
Intangibles To Total Assets7.0E-47.0E-40.0231
Slightly volatile
Current Ratio2.222.3415.3603
Slightly volatile
Receivables Turnover5.025.293.8029
Slightly volatile
Capex Per Share0.140.07470.2541
Slightly volatile
Average Receivables482 K445.6 K453.9 K
Slightly volatile
Revenue Per Share1.651.111.0529
Pretty Stable
Interest Debt Per Share3.223.399.0916
Slightly volatile
Debt To Assets0.71.130.6356
Slightly volatile
Graham Number8.849.38.4866
Pretty Stable
Operating Cycle176186533
Very volatile
Days Of Payables Outstanding157166410
Slightly volatile
Ebt Per Ebit0.791.011.0235
Pretty Stable
Total Debt To Capitalization1.921.830.8415
Slightly volatile
Quick Ratio1.922.0214.9459
Slightly volatile
Net Income Per E B T0.740.910.9643
Pretty Stable
Cash Ratio1.11.169.3353
Slightly volatile
Days Of Inventory Outstanding1391461.5 K
Slightly volatile
Days Of Sales Outstanding86.791.27183
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.161.181.0616
Pretty Stable
Fixed Asset Turnover2.592.735.4266
Slightly volatile
Debt Ratio0.71.130.6356
Slightly volatile
Price Sales Ratio3.473.652.3 K
Slightly volatile
Asset Turnover0.460.440.1756
Pretty Stable

Accelerate Diagnostics Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap9.9 M10.4 M14.4 M
Slightly volatile
Enterprise Value9.6 M10.1 M13.6 M
Slightly volatile

Accelerate Fundamental Market Drivers

Cash And Short Term Investments13.2 M

Accelerate Upcoming Events

3rd of April 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
3rd of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Accelerate Diagnostics Financial Statements

Accelerate Diagnostics investors use historical fundamental indicators, such as Accelerate Diagnostics' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Accelerate Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue1.8 M1.9 M
Total Revenue13.9 M14.6 M
Cost Of Revenue10.9 M7 M
Stock Based Compensation To Revenue 0.51  0.49 
Sales General And Administrative To Revenue 80.38  84.40 
Research And Ddevelopement To Revenue 1.89  1.80 
Capex To Revenue 0.08  0.07 
Revenue Per Share 1.11  1.65 
Ebit Per Revenue(5.15)(5.41)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
CRMSalesforce
CRMSalesforce

Additional Tools for Accelerate Stock Analysis

When running Accelerate Diagnostics' price analysis, check to measure Accelerate Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accelerate Diagnostics is operating at the current time. Most of Accelerate Diagnostics' value examination focuses on studying past and present price action to predict the probability of Accelerate Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accelerate Diagnostics' price. Additionally, you may evaluate how the addition of Accelerate Diagnostics to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY